These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
858 related articles for article (PubMed ID: 12661753)
1. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Baker D; Eisen D Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753 [TBL] [Abstract][Full Text] [Related]
2. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902 [TBL] [Abstract][Full Text] [Related]
3. Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study. Gilbert SC J Drugs Dermatol; 2007 Apr; 6(4):400-5. PubMed ID: 17668537 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. Warren T; Harris J; Brennan CA Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897 [TBL] [Abstract][Full Text] [Related]
5. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Fife KH; Warren TJ; Justus SE; Heitman CK; Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016 [TBL] [Abstract][Full Text] [Related]
6. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial. Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557 [TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210 [TBL] [Abstract][Full Text] [Related]
8. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life. Handsfield HH; Warren T; Werner M; Phillips JA Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847 [TBL] [Abstract][Full Text] [Related]
9. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071 [TBL] [Abstract][Full Text] [Related]
10. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial. Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA; J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350 [TBL] [Abstract][Full Text] [Related]
11. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial. Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755 [TBL] [Abstract][Full Text] [Related]
12. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068 [TBL] [Abstract][Full Text] [Related]
13. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Leone PA; Trottier S; Miller JM Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962 [TBL] [Abstract][Full Text] [Related]
14. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Miserocchi E; Modorati G; Galli L; Rama P Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271 [TBL] [Abstract][Full Text] [Related]
16. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Aurelius E; Franzen-Röhl E; Glimåker M; Akre O; Grillner L; Jorup-Rönström C; Studahl M; Clin Infect Dis; 2012 May; 54(9):1304-13. PubMed ID: 22460966 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396 [TBL] [Abstract][Full Text] [Related]
18. Valacyclovir. New indication: for genital herpes, simpler administration. Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269 [TBL] [Abstract][Full Text] [Related]
19. Prophylactic valacyclovir in a patient with recurrent vestibular disturbances secondary to vestibular neuritis. Amber KT; Castaño JE; Angeli SI Am J Otolaryngol; 2012; 33(4):487-8. PubMed ID: 22154065 [TBL] [Abstract][Full Text] [Related]
20. Valacyclovir for the treatment of genital herpes. Brantley JS; Hicks L; Sra K; Tyring SK Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]